期刊文献+

YAP蛋白在大肠新生物发生发展中的研究进展

Research Advances in Role of Yes-Associated Protein in the Development of Colorectal Neoplasia
下载PDF
导出
摘要 大肠癌是最常见的恶性肿瘤之一,随着内镜早期筛查诊断的普及和手术药物等治疗方法的改进,患者预后已有较大改善,但病死率仍较高,故需进一步阐述其发生的分子机制,以寻求更好的诊断方法、预后指标和治疗方法。YAP蛋白作为共转录因子,参与调控细胞增殖和凋亡相关基因的表达,可与在大肠癌发生发展中起重要作用的Wnt/β联蛋白通路及APC蛋白交叉协同。当前,围绕YAP蛋白作为致癌因子及潜在药物靶点机制的研究吸引了许多学科的关注。 Colorectal cancer is one of the most common malignant tumors. With the popularization of endoscopic diagnosis for early stage colorectal cancer and the progress of surgical and medical treatments,the patient prognosis has improved greatly,but the mortality remains high,so the molecular mechanism still needs to be further elaborated to seek better diagnosis method,prognosis biomarker and treatment method. Yes-associated protein( YAP) as a transcription factor,participates in the regulation of cell proliferation and apoptosis and interacts with Wnt/β-catenin pathway and adenomatous polyposis coli( APC) protein in the development of colorectal cancer. Currently,the mechanistic research on YAP protein as an oncogene and potential drug target mechanism has attracted attention from many disciplines.
作者 吕俊衍 李春媚 魏云华 马岚青 LYU Junyan;LI Chunmei;WEI Yunhua;MA Lanqing(Department of Gastroenterology,the First Affiliated Hospital of Kunming Medical University,Kunming 650032,China)
出处 《医学综述》 2019年第6期1041-1046,共6页 Medical Recapitulate
基金 国家自然科学基金(81560099)
关键词 YAP蛋白 Hippo信号通路 大肠新生物 Wnt/β联蛋白通路 Yes-associated protein Hippo signaling pathway Colorectal neoplasia Wnt/β-catenin pathway
  • 相关文献

参考文献2

二级参考文献25

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Wheeler JM, 13odrner WF, Mortensen NJ. DNA mismatcla repair genes and colorectal cancer [J]. Gut, 2000, 47 ( 1 ) : 148-153.
  • 3Weber TK, Conlon W, Petrelli NJ, et al. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees [J].Cancer Res, 1997, 57: 3798-3803.
  • 4Haydon AMM,Jass JR, Emerging pathways in colorectal cancer development [J]. Lancet Oncol, 2002, 3 (2): 83-88.
  • 5Jassa JR,Walsh MD, Barker M, et al. Distinction between familial and sporadic forms of colorectal cancer showing DNA misrosatellite instability [J]. Eur J Cancer, 2002, 38: 858-866.
  • 6Herman JG,Umar A, Polyak K, et al. lnctdence and tuneuonai consequences of hMLH1 promoter hypermethylation in colorectal carcinoma [J]. Proe Natl Aead Sci USA, 1998, 95 (12):6870-6875.
  • 7Wheeler JMD,Llukola A, Aaltonen LA, etal. The role of hypermethylation of the hMLH1 promoter region in HNPCC versns MSI+ sporadie colerectal cancers[J]. J Med Genet, 2000, 37(8): 588-592.
  • 8Golijon C, Gnerci A,Mouron s, et al. Activation of k - ras and c- erbB- 2 protooncogenes in human colonic adenocarcinomas[J]. Acta Gastroentemlogical Latinoamericana, 2001, 31 (2):71 -76.
  • 9Aaltonen LA,Peltomaki P, et al. clues to the pathogenesis of familial eolorectal cancer [J]. Science, 1993, 260: 812-816.
  • 10陈坤 焦登鳌 余海.人群大肠癌筛检数量化方法的应用研究[J].实用肿瘤研究,2003,18:68-70.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部